Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q2 FY2022 Earnings Presentation
28 slides from Zota Health Care's earnings presentation, Dec 27, 2021
Slide 1: Cover letter to NSE on unaudited financial results
A zoto' rheNati.nalsto.k Er.han3€orrndia Limit.d Bandm (r), Mumba -4000s1 Ref:Resur*ion30ofsEBrokrinsobtisarionsandDi.dorur.RequiEm B)Resut*ioB, r01s with refer.n.e r. rh..apr oied subl.dwe, zob He:rth c e Lm ted are subm nins herewirh encosed ofumud ted f nan.hlResuk forthe quafrerended september 3
Slide 2: Q2FY22 Performance Highlights
Q2FY22 PERFORMANCE HIGHLIGHTS DECEMBER 2021
Slide 3: Safe Harbour
Safe Harbour This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer
Slide 4: Table Of Contents
Table Of Contents 01 RESULT HIGHLIGHTS 02 OPERATIONAL METRICS 03 DAVAINDIA BUSINESS OUTLOOK 04 & STRATEGY 05 FINANCIAL SUMMARY zotahealthcare.com
Slide 5: Q2FY22 Result Highlights
Q2FY22- Result Highlights zotahealthcare.com
Slide 6: Standalone Quarterly Financial Highlights
Stand Quarterly Financial Highlights Q-o-Q Revenues (₹ Lakhs) Gross Profit (%) Operating Profit (₹ Lakhs) PAT (₹ Lakhs) Q2-FY22 3,539.70 Q2-FY22 33.82% Q2-FY22 493.62 Q2-FY22 331.63 Q1-FY22 3,344.49 Q1-FY22 34.02% Q1-FY22 488.62 Q1-FY22 337.41 Y-o-Y Revenues (₹ Lakhs) Gross Profit (%) Operating Prof
Slide 7: Revenue Break up – Quarterly
Revenue Break up – Quarterly Domestic Sales Dava India Sales Export Sales (SEZ) 1,815.1 896.8 848.1 991.7 1,699.9 575.0 685.1 632.6 1,556.6 Q2-FY21 Q1-FY22 Q2-FY22 Q2-FY21 Q1-FY22 Q2-FY22 Q2-FY21 Q1-FY22 Q2-FY22 06 zotahealthcare.com
Slide 8: FY Result Highlights
FY- Result Highlights zotahealthcare.com
Slide 9: Standalone Profit & Loss Statement - Quarterly
Stand Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q2FY22 Q1FY22 YoY % QoQ % Q2FY21 Export Sales (SEZ) 991.7 632.6 45% 57% 685.1 Dava India Sales 848.1 896.8 47% -5% 575.0 Domestic Sales 1699.9 1,815.1 9% -6% 1,556.6 Revenues from Operations 3,539.70 3,344.49 26% 6% 2,816.64 Cost of Go
Slide 10: Management Commentary
Management Commentary 01 The Company recorded best- 02 Exports performance 03 The sales contribution from ever quarterly Revenues in recovered well with a 57% new-age business stood at Q2FY22, while emerging from increase QoQ, after a 52% in Q2FY22 as compared a challenging external subdued Q1FY22 d
Slide 11: Management Commentary
Management Commentary DOMESTIC OPERATIONS Domestic Revenues EBITDA at ₹ 343.38 PAT stood at ₹ registered a decline of Lakhs for Q2FY22, 205.76 Lakhs for (6.04)% QoQ and a growth of backed by strong Q2FY22. 19.53% YoY at ₹ 2548.0 Lakhs recovery in demand supported by healthy of Prescription Based per
Slide 12: Davaindia Generic Pharmacy
Davaindia Generic Pharmacy zotahealthcare.com
Slide 13: Davaindia Key Figures
Davaindia Key Figures Gross Mercantile Value (GMV) Total GMV of Davaindia Stores stood at 1401.69 Lakhs during Q2FY22. No. of SKU’s New Stores rolled-out 1,585 65 1,503 49 Q1-FY22 Q2-FY22 Q1-FY22 Q2-FY22 12 zotahealthcare.com
Slide 14: Davaindia Key Figures: Customers and Wallet Spend
zotahealthcare.com 5,40,924 Q2-FY22 4,73,181 Q1-FY22 No. of Customers Served 4,40,458 Q4-FY21 3,23,395 Q3-FY21 3,52,623 Q2-FY21 3,38,415 Q1-FY21 2,75,520 Q4-FY20 Davaindia Key Figures 2,67,030 Q3-FY20 2,59,022 Q2-FY20 229 Q2-FY22 220 Q1-FY22 204 Q4-FY21 Average Wallet Spend 209 Q3-FY21 181 Q2-FY21 1
Slide 15: Davaindia- Generic Pharmacy
Davaindia- Generic Pharmacy During the quarter Davaindia has Davaindia has led the revolution of Davaindia retail pharmacy stores’ catered to the highest-ever number of patients opting for generic medicines focus continues to be chronic ailments customer i.e. 5.41 lakhs against 4.73 against branded
Slide 16: Davaindia- Generic Pharmacy
Davaindia- Generic Pharmacy 15 zotahealthcare.com
Slide 17: Davaindia- COCO Stores
Davaindia- COCO Stores 16 zotahealthcare.com
Slide 18: Operational FOFO Stores
Operational FOFO Stores 425 States Arunachal Pradesh Assam No. of Stores 1 6 OPERATIONAL FOFO STORES AS Bihar 9 ON 30.09.2021 Chhattisgarh 1 Delhi 25 Goa 1 Gujarat 55 Haryana 22 Himachal Pradesh 1 Jammu And Kashmir 2 Jharkhand 7 Karnataka 8 Kerala 13 Madhya Pradesh 64 Maharashtra 45 Meghalaya 1 Odis
Slide 19: Operational COCO Stores
Operational COCO Stores 4 Cities Surat Palanpur No. of Stores 3 1 OPERATIONAL COCO STORES AS ON 30.09.2021 Legend Company Owned Company Operated (COCO) Stores 18 Operated by wholly-owned subsidiary zotahealthcare.com Davaindia Health Mart Limited
Slide 20: Management Commentary
Management Commentary Commenting on Q2FY22 financial performance and operational highlights, Management Team of Zota Health Care said, “We are satisfied with the overall performance of the Company in Q2FY22. Q2FY22 witnessed the highest ever quarterly revenue Zota has reported, led by good performan
Slide 21: Industry Snapshot & Business Strategy
Industry Snapshot & Business Strategy zotahealthcare.com
Slide 22: Retail Generic Medicine Landscape in India
Retail Generic Medicine Landscape in India To achieve the objective of making available quality generic medicines at affordable prices to all, ‘Jan Aushadhi Scheme’ was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India across the county. The sche
Slide 23: Impact of PMBJP
Impact of PMBJP In the financial year (2019-20), PMBJP has achieved sales of ₹258 crores (at MRP), up to 30-11-2019. This has led to savings of approximately ₹1,800 crores of the common citizens of the country. Growth in number of stores Growth in turnover Product basket Price of Janaushadhi medicin
Slide 24: Underpenetrated Generic Medicine Market
Underpenetrated Generic Medicine Market 4 pillars to drive Branded and generic mix of Indian healthcare pharma market (%) Overall India Urban India Rural India 4 As of healthcare 8 6 15 1 Accessibility 2 Affordability 3 Awarness 4 Aliments 92 94 85 • Setting up of new • Higher per capita • Rising li
Slide 25: Financial Summary
Financial Summary zotahealthcare.com
Slide 26: Profit & Loss Statement
Profit & Loss Statement Particulars (INR Lakhs) FY15 FY16 FY17 FY18 FY19 FY20 FY21 Income from Operations 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 10678.92 Other Income 1.4 7.7 5.6 151.9 154.5 151.3 125.97 Total Income 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 10804.89 Operating Expense
Slide 27: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 4,173.6 Non-current liabilities 521.3 548.7 272.7 466.8 64.7
Slide 28: Thank You
Thank You Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com